SHPH — Shuttle Pharmaceuticals Holdings Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:37 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Shuttle Pharmaceuticals Holdings Inc - Appoints Yuying Liang As CFO - SEC Filing
Brief: Shuttle Pharmaceuticals Holdings Inc - Timothy Lorber Resigns As CFO Of Shuttle Pharmaceuticals - SEC Filing
Brief: Shuttle Pharmaceuticals Holdings Inc - Enters Binding Term Sheet With Molecule - SEC Filing
Brief: Shuttle Pharmaceuticals Announces Letter Of Intent With Molecule.Ai
Brief: Shuttle Pharmaceuticals Announces Closing Of $4.25 Million Private Placement Priced At-The-Market
Brief: Shuttle Pharma Announces Reverse Stock Split Will Become Effective On June 16
Brief: Shuttle Pharma Appoints George Scorsis Chairman Of The Board Of Directors
Brief: Shuttle Pharmaceuticals Holdings Implements 70% Salary Reduction For Executives - SEC Filing
Brief: Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer
Brief: Shuttle Pharmaceuticals Holdings Inc - On March 21, Enters Consulting Agreement With Bowery Consulting - SEC Filing
Brief: Shuttle Pharma Announces Closing Of $5.75 Million Underwritten Offering
CEO To Enhance Business Activities
Brief: Shuttle Pharmaceuticals Holdings Offers Up To 10,000,000 Shares Of Common Stock
Brief: Shuttle Pharmaceuticals Holdings Enters $2 Million Revolving Loan Agreement
Brief: Shuttle Pharma Expands Patient Enrollment For Phase 2 Clinical Trial
Brief: Shuttle Pharmaceuticals Holdings Announces Pricing Of $4.5 Mln Public Offering